{
  "meta": {
    "title": "23_Sphingolipidoses",
    "url": "https://brainandscalpel.vercel.app/23-sphingolipidoses-d379b1ac.html",
    "scrapedAt": "2025-11-30T06:55:59.079Z"
  },
  "questions": [
    {
      "id": 92708,
      "choices": [
        {
          "id": 258220,
          "text": "Pompe’s disease"
        },
        {
          "id": 258221,
          "text": "Krabbe’s disease"
        },
        {
          "id": 258222,
          "text": "Fabry’s disease"
        },
        {
          "id": 258223,
          "text": "Gaucher’s disease"
        }
      ],
      "text": "Deficiency of glucocerebrosidase cause",
      "unique_key": "Q1636381",
      "question_audio": null,
      "question_video": null,
      "map_id": 34019001,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Gaucher’s disease Gaucher's disease is caused by a deficiency in the enzyme glucocerebrosidase. This enzyme is responsible for breaking down glucocerebroside, a type of sphingolipid. When glucocerebrosidase is deficient or inactive, glucocerebroside accumulates in certain cells, particularly in macrophages, leading to the formation of Gaucher cells. These cells accumulate in various organs, including the liver, spleen, and bone marrow, causing symptoms like enlargement of the spleen (splenomegaly), liver (hepatomegaly), bone pain, and fractures. Gaucher’s disease is one of the most common lysosomal storage disorders. Why other options are incorrect: (A) Pompe’s disease Pompe's disease is caused by a deficiency in acid alpha-glucosidase (also known as acid maltase), an enzyme responsible for breaking down glycogen in lysosomes. This leads to glycogen accumulation in muscles, causing muscle weakness and respiratory problems. While it is a lysosomal storage disorder, it is unrelated to glucocerebrosidase deficiency. (B) Krabbe’s disease Krabbe's disease is caused by a deficiency in galactocerebrosidase, an enzyme involved in the breakdown of galactocerebroside, a type of sphingolipid. The accumulation of galactocerebroside leads to damage of the myelin sheath in the nervous system, causing neurological symptoms. This is different from Gaucher's disease, which involves glucocerebrosidase. (C) Fabry’s disease Fabry's disease is caused by a deficiency in alpha-galactosidase A, an enzyme responsible for breaking down globotriaosylceramide (a type of sphingolipid). The accumulation of this lipid leads to symptoms affecting the kidneys, heart, and skin. Fabry's disease is distinct from Gaucher's disease, as it involves different enzymes and lipid substrates.",
      "correct_choice_id": 258223,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46293471704711723/46293471704711723.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46293471704711723/46293471704711723.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92709,
      "choices": [
        {
          "id": 258224,
          "text": "Farber’s disease"
        },
        {
          "id": 258225,
          "text": "Niemann-Pick disease"
        },
        {
          "id": 258226,
          "text": "Krabbe’s disease"
        },
        {
          "id": 258227,
          "text": "Tay-sachs disease"
        }
      ],
      "text": "Deficiency of sphingomylinase cause",
      "unique_key": "Q7009462",
      "question_audio": null,
      "question_video": null,
      "map_id": 34827607,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Niemann-Pick disease Niemann-Pick disease is caused by a deficiency in sphingomyelinase, the enzyme responsible for breaking down sphingomyelin, a type of sphingolipid. When sphingomyelinase is deficient or inactive, sphingomyelin accumulates in lysosomes, particularly in macrophages, leading to damage in various organs, including the liver, spleen, and brain. This accumulation results in symptoms such as enlargement of the liver and spleen (hepatosplenomegaly), neurological deterioration, and developmental delay. There are several types of Niemann-Pick disease, with types A and B being associated with sphingomyelinase deficiency. Why other options are incorrect: (A) Farber’s disease Farber's disease is caused by a deficiency in ceramidase, an enzyme involved in the breakdown of ceramide, a sphingolipid. The accumulation of ceramide leads to symptoms such as joint deformities, swelling, and a hoarse voice. This is unrelated to sphingomyelinase deficiency. (C) Krabbe’s disease Krabbe's disease is caused by a deficiency in galactocerebrosidase, an enzyme responsible for breaking down galactocerebroside, a sphingolipid. The buildup of galactocerebroside leads to severe neurological symptoms, including the loss of myelin in the nervous system. It does not involve sphingomyelinase deficiency. (D) Tay-Sachs disease Tay-Sachs disease is caused by a deficiency in hexosaminidase A, an enzyme that breaks down GM2 ganglioside, a type of ganglioside (a type of glycolipid). The accumulation of GM2 ganglioside leads to progressive neurological deterioration. This is not related to sphingomyelinase deficiency.",
      "correct_choice_id": 258225,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21614481704711755/21614481704711755.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21614481704711755/21614481704711755.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92710,
      "choices": [
        {
          "id": 258228,
          "text": "Niemann-Pick disease"
        },
        {
          "id": 258229,
          "text": "Krabbe’s disease"
        },
        {
          "id": 258230,
          "text": "Gaucher’s disease"
        },
        {
          "id": 258231,
          "text": "Tay-sach disease"
        }
      ],
      "text": "Beta-galactosidase deficiency cause",
      "unique_key": "Q3499913",
      "question_audio": null,
      "question_video": null,
      "map_id": 34801223,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Krabbe’s disease Krabbe’s disease is caused by a deficiency in galactocerebrosidase, an enzyme responsible for breaking down galactocerebroside, a type of sphingolipid. Without this enzyme, galactocerebroside accumulates, particularly in the nervous system, leading to progressive demyelination. This disease is characterized by severe neurological symptoms, such as irritability, muscle weakness, developmental delays, and vision problems. Krabbe's disease typically presents in infancy and progresses rapidly, often resulting in death within the first few years of life. Why other options are incorrect: (A) Niemann-Pick disease Niemann-Pick disease is caused by a deficiency in sphingomyelinase, the enzyme responsible for breaking down sphingomyelin. The accumulation of sphingomyelin leads to hepatosplenomegaly, neurological deterioration, and other organ-related symptoms, which is not linked to a galactocerebrosidase deficiency. (C) Gaucher’s disease Gaucher’s disease is caused by a deficiency in glucocerebrosidase, which leads to the accumulation of glucocerebroside in macrophages. This disease primarily affects the liver, spleen, and bone marrow, resulting in hepatosplenomegaly, anemia, bone pain, and fractures, but it is not caused by galactocerebrosidase deficiency. (D) Tay-Sachs disease Tay-Sachs disease is caused by a deficiency in hexosaminidase A, which is responsible for breaking down GM2 ganglioside. The accumulation of GM2 ganglioside in neurons leads to progressive neurodegeneration, but it is not related to galactocerebrosidase deficiency.",
      "correct_choice_id": 258229,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34868741704711771/34868741704711771.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34868741704711771/34868741704711771.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92711,
      "choices": [
        {
          "id": 258232,
          "text": "Tay-Sachs disease"
        },
        {
          "id": 258233,
          "text": "Gaucher’s disease"
        },
        {
          "id": 258234,
          "text": "Krabbe’s disease"
        },
        {
          "id": 258235,
          "text": "Niemann-Pick disease"
        },
        {
          "id": 258236,
          "text": "Hurler syndrome"
        }
      ],
      "text": "Hexosaminidase A deficiency cause",
      "unique_key": "Q4502133",
      "question_audio": null,
      "question_video": null,
      "map_id": 34078634,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Tay-Sachs disease Tay-Sachs disease is caused by a deficiency in hexosaminidase A, an enzyme that breaks down GM2 ganglioside in neurons. When this enzyme is deficient, GM2 ganglioside accumulates in the nerve cells, leading to severe neurodegeneration. This condition primarily affects infants, who begin to show symptoms such as developmental regression, muscle weakness, seizures, and vision loss around six months of age. Tay-Sachs disease is fatal, typically by the age of 4-5 years, due to the progressive destruction of nerve cells. Why other options are incorrect: (B) Gaucher’s disease Gaucher’s disease is caused by a deficiency in glucocerebrosidase, an enzyme that breaks down glucocerebroside. In Gaucher’s disease, glucocerebroside accumulates in macrophages, leading to symptoms such as hepatosplenomegaly, bone pain, and anemia. This is unrelated to hexosaminidase A deficiency. (C) Krabbe’s disease Krabbe’s disease is caused by a deficiency in galactocerebrosidase, leading to the accumulation of galactocerebroside in the nervous system. It results in demyelination and severe neurological deterioration. It is not linked to a deficiency in hexosaminidase A. (D) Niemann-Pick disease Niemann-Pick disease is caused by a deficiency in sphingomyelinase, leading to the accumulation of sphingomyelin in cells, particularly in the liver and spleen. This results in hepatosplenomegaly and neurological symptoms but is not related to hexosaminidase A deficiency. (E) Hurler syndrome Hurler syndrome (also known as mucopolysaccharidosis type I) is caused by a deficiency in alpha-L-iduronidase, which results in the accumulation of heparan sulfate and dermatan sulfate. This condition is associated with developmental delays, skeletal deformities, and organ enlargement. It is not associated with hexosaminidase A deficiency.",
      "correct_choice_id": 258232,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6033981704711786/6033981704711786.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6033981704711786/6033981704711786.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92712,
      "choices": [
        {
          "id": 258237,
          "text": "Gaucher’s disease"
        },
        {
          "id": 258238,
          "text": "Down’s syndrome"
        },
        {
          "id": 258239,
          "text": "Niemann-Pick disease"
        },
        {
          "id": 258240,
          "text": "Tay-sachs disease"
        }
      ],
      "text": "Accumulation of sphingomyelin in phagocytes occur in",
      "unique_key": "Q9997997",
      "question_audio": null,
      "question_video": null,
      "map_id": 34767550,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Niemann-Pick disease In Niemann-Pick disease, there is a deficiency of the enzyme sphingomyelinase, which is responsible for breaking down sphingomyelin, a type of lipid. This enzyme deficiency leads to the accumulation of sphingomyelin in phagocytic cells (such as macrophages) and other tissues, especially in the liver, spleen, and brain. This accumulation causes a variety of symptoms, including hepatosplenomegaly (enlarged liver and spleen), neurological problems, and respiratory difficulties. Niemann-Pick disease is classified into different types, with Type A being the most severe form, often leading to early death in childhood. Why other options are incorrect: (A) Gaucher’s disease Gaucher’s disease is caused by a deficiency in the enzyme glucocerebrosidase, leading to the accumulation of glucocerebroside in macrophages, not sphingomyelin. The buildup of glucocerebroside results in enlarged spleen and liver, bone pain, and other symptoms, but it does not cause the accumulation of sphingomyelin. (B) Down’s syndrome Down’s syndrome is a genetic condition caused by trisomy 21, resulting in cognitive impairment and other developmental delays. It does not involve the accumulation of sphingomyelin or relate to lipid storage disorders. The pathophysiology of Down’s syndrome is different and unrelated to sphingomyelin accumulation in phagocytes. (D) Tay-Sachs disease Tay-Sachs disease is caused by a deficiency of the enzyme hexosaminidase A, leading to the accumulation of GM2 ganglioside in nerve cells. This causes neurodegeneration, but it does not involve sphingomyelin accumulation. Tay-Sachs primarily affects neurons in the central nervous system, not phagocytes.",
      "correct_choice_id": 258239,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75539991704711805/75539991704711805.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75539991704711805/75539991704711805.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92713,
      "choices": [
        {
          "id": 258241,
          "text": "GM1 gangliosides"
        },
        {
          "id": 258242,
          "text": "GM2 gangliosides"
        },
        {
          "id": 258243,
          "text": "Galactocerebroside"
        },
        {
          "id": 258244,
          "text": "Glucocerebroside"
        }
      ],
      "text": "Tay-Sachs disease is due to accumulation of",
      "unique_key": "Q3421932",
      "question_audio": null,
      "question_video": null,
      "map_id": 34278530,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) GM2 gangliosides Tay-Sachs disease is caused by a deficiency of the enzyme hexosaminidase A, which is responsible for breaking down GM2 gangliosides. When this enzyme is deficient, GM2 gangliosides accumulate in the neurons of the brain and spinal cord, leading to severe neurodegeneration. This accumulation results in the characteristic symptoms of Tay-Sachs, including developmental regression, loss of motor skills, seizures, and eventually death, usually in early childhood. The accumulation of GM2 gangliosides is the key pathological feature of Tay-Sachs disease. Why other options are incorrect: (A) GM1 gangliosides GM1 gangliosides are the substrate for the enzyme GM1 ganglioside activator and are involved in GM1 gangliosidosis, which is a different lysosomal storage disorder. In GM1 gangliosidosis, the accumulation of GM1 gangliosides occurs due to a deficiency of the enzyme Beta-galactosidase, not hexosaminidase A. This is distinct from Tay-Sachs disease, which specifically involves the accumulation of GM2 gangliosides. (C) Galactocerebroside Galactocerebroside is a type of lipid that accumulates in Krabbe’s disease, a different lysosomal storage disorder caused by a deficiency in the enzyme galactocerebrosidase. It is not associated with Tay-Sachs disease, which involves GM2 ganglioside accumulation, not galactocerebroside. (D) Glucocerebroside Glucocerebroside accumulates in Gaucher’s disease, another lysosomal storage disorder. Gaucher’s disease is due to a deficiency of the enzyme glucocerebrosidase, leading to the accumulation of glucocerebroside in macrophages and other tissues, but not in neurons like in Tay-Sachs.",
      "correct_choice_id": 258242,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17859611704711825/17859611704711825.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17859611704711825/17859611704711825.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92714,
      "choices": [
        {
          "id": 258245,
          "text": "Sphingomyelin"
        },
        {
          "id": 258246,
          "text": "Gangliosides"
        },
        {
          "id": 258247,
          "text": "Glucocerebroside"
        },
        {
          "id": 258248,
          "text": "Galactocerebroside"
        }
      ],
      "text": "A child present with pancytopenia, neck rigidity, hypertonia, fatal bronchopneumonia. Bone marrow biopsy result shows ‘crumbled tissue paper appearance’ because of accumulation of",
      "unique_key": "Q2675777",
      "question_audio": null,
      "question_video": null,
      "map_id": 34248791,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Glucocerebroside The presentation described, including pancytopenia, neck rigidity, hypertonia, and fatal bronchopneumonia, is characteristic of Gaucher’s disease. In this disorder, there is a deficiency of the enzyme glucocerebrosidase, which leads to the accumulation of glucocerebroside in macrophages, including in the bone marrow. The classic \"crumpled tissue paper\" appearance seen in the bone marrow biopsy is due to the storage of glucocerebroside in the cytoplasm of macrophages. These macrophages, known as Gaucher cells, appear with this distinctive appearance when viewed under a microscope. Gaucher’s disease is a lysosomal storage disorder and can cause a range of symptoms, including bone pain, anemia, fatigue, and splenomegaly, which can be fatal if not treated. Why other options are incorrect: (A) Sphingomyelin Sphingomyelin is the substance that accumulates in Niemann-Pick disease, which is caused by a deficiency in the enzyme sphingomyelinase. Niemann-Pick disease also affects the bone marrow and can lead to organomegaly, but the \"crumpled tissue paper\" appearance in the bone marrow is specifically associated with Gaucher's disease, not Niemann-Pick disease. (B) Gangliosides Gangliosides, particularly GM2 gangliosides, accumulate in Tay-Sachs disease. This condition leads to progressive neurological decline but does not involve the bone marrow or the \"crumpled tissue paper\" appearance. Gangliosides are lipid molecules that affect the nervous system primarily, not the bone marrow in the same way glucocerebrosides do. (D) Galactocerebroside Galactocerebroside accumulates in Krabbe’s disease, a lysosomal storage disorder caused by a deficiency of galactocerebrosidase. Krabbe’s disease typically presents with symptoms like irritability, muscle weakness, and loss of developmental milestones but does not lead to the characteristic \"crumpled tissue paper\" appearance seen in Gaucher’s disease.",
      "correct_choice_id": 258247,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/9051631704711840/9051631704711840.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/9051631704711840/9051631704711840.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92715,
      "choices": [
        {
          "id": 258249,
          "text": "Phytanic acid lyase"
        },
        {
          "id": 258250,
          "text": "Phytanic acid isomerase"
        },
        {
          "id": 258251,
          "text": "Phytanic acid reductase"
        },
        {
          "id": 258252,
          "text": "Phytanic acid oxidase"
        }
      ],
      "text": "Refsum disease is due to deficiency of",
      "unique_key": "Q4570648",
      "question_audio": null,
      "question_video": null,
      "map_id": 34156809,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Phytanic acid oxidase Refsum disease is a rare inherited disorder caused by the deficiency of the enzyme phytanic acid oxidase. This enzyme is responsible for the Beta-oxidation of phytanic acid, a branched-chain fatty acid. In Refsum disease, the deficiency of this enzyme leads to the accumulation of phytanic acid in tissues, including the blood and nervous system. Symptoms of Refsum disease include peripheral neuropathy, cerebellar ataxia, retinitis pigmentosa, and cardiac arrhythmias, among others. The buildup of phytanic acid causes progressive damage to the nervous system and other organs. Why other options are incorrect: (A) Phytanic acid lyase Phytanic acid lyase is involved in the degradation of phytanic acid in a different metabolic pathway, but its deficiency is not the cause of Refsum disease. The primary defect in Refsum disease is in the enzyme phytanic acid oxidase, not phytanic acid lyase. (B) Phytanic acid isomerase Phytanic acid isomerase is involved in the isomerization process of phytanic acid during its metabolism. A deficiency in this enzyme would affect the conversion of phytanic acid but is not the cause of Refsum disease. Refsum disease is specifically related to the defect in phytanic acid oxidase. (C) Phytanic acid reductase Phytanic acid reductase is another enzyme involved in phytanic acid metabolism, but its deficiency does not lead to Refsum disease. Refsum disease is caused by the lack of phytanic acid oxidase, not by a deficiency of reductase.",
      "correct_choice_id": 258252,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49548031704711863/49548031704711863.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49548031704711863/49548031704711863.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}